Procalcitonin Levels in Patients with Complete and Incomplete Kawasaki Disease

Figure 1

Laboratory data from patients with complete Kawasaki disease (KD), incomplete KD, and other febrile illnesses (controls), collected on the day of diagnosis and 2, 14, and 56 days after intravenous immunoglobulin (IVIG) treatment. (a) White blood cell count, (b) C-reactive protein level, (c) erythrocyte sedimentation rate, and (d) N-terminal pro-brain natriuretic protein (NT-proBNP) level. ^†𝑃<0.05 versus day of diagnosis in children with complete KD, ^∗𝑃<0.05 versus day of diagnosis in children with incomplete KD. ^§𝑃<0.05; a statistically significant difference was evident between the complete KD group and controls. ^∫𝑃<0.05; a statistically significant difference was evident between the incomplete KD group and controls.

(a)

(b)

(c)

(d)